Galvanic stimulation for Parkinson's Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Parkinson's DiseaseGalvanic stimulation - Device
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help determine if multimodal non-invasive neuromodulation can help improve symptoms in PD patients.

Treatment Effectiveness

Study Objectives

4 Primary · 4 Secondary · Reporting Duration: Baseline to week 4

Baseline to week 4
Electroencephalography - amplitudes
Electroencephalography - latencies
MiniBESTest
Montreal Cognitive Assessment (MoCA)
NeuroCom Adaptation Test
NeuroCom Limits of Stability test (LOS)
NeuroCom Sensory Organization Test (SOT)
Unified Parkinson's Disease Rating Scale

Trial Safety

Trial Design

4 Treatment Groups

Physiotherapy only
1 of 4
Active galvanic stimulation (GVS; week 1) to sham GVS (week 2)
1 of 4
Sham GVS (week 1) to active GVS (week 2)
1 of 4
Active GVS throughout weeks 1 + 2
1 of 4

Active Control

Experimental Treatment

32 Total Participants · 4 Treatment Groups

Primary Treatment: Galvanic stimulation · No Placebo Group · N/A

Active galvanic stimulation (GVS; week 1) to sham GVS (week 2)
Device
Experimental Group · 1 Intervention: Galvanic stimulation · Intervention Types: Device
Sham GVS (week 1) to active GVS (week 2)
Device
Experimental Group · 1 Intervention: Galvanic stimulation · Intervention Types: Device
Active GVS throughout weeks 1 + 2
Device
Experimental Group · 1 Intervention: Galvanic stimulation · Intervention Types: Device
Physiotherapy onlyNoIntervention Group · 1 Intervention: Physiotherapy only · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to week 4

Who is running the clinical trial?

Ryan D'ArcyLead Sponsor
Pacific Parkinson's Research InstituteUNKNOWN
University of British ColumbiaOTHER
1,325 Previous Clinical Trials
1,534,061 Total Patients Enrolled

Eligibility Criteria

Age Any Age · All Participants · 9 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be able to understand and complete all assessments (provided in English only).
You have idiopathic Parkinson's disease.
You must be able to voluntarily give informed consent.